Encompass Health
544 hedge funds and large institutions have $8.84B invested in Encompass Health in 2024 Q4 according to their latest regulatory filings, with 98 funds opening new positions, 208 increasing their positions, 163 reducing their positions, and 31 closing their positions.
216% more first-time investments, than exits
New positions opened: 98 | Existing positions closed: 31
161% more call options, than puts
Call options by funds: $10.1M | Put options by funds: $3.86M
28% more repeat investments, than reductions
Existing positions increased: 208 | Existing positions reduced: 163
13% more funds holding
Funds holding: 483 → 544 (+61)
0.1% less ownership
Funds ownership: 95.14% → 95.04% (-0.1%)
4% less capital invested
Capital invested by funds: $9.24B → $8.84B (-$397M)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$163M |
| 2 |
Jennison Associates
New York
|
+$55.4M |
| 3 |
BlackRock
New York
|
+$52.3M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$45M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$39.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
-$142M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$117M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$84M |
| 4 |
Millennium Management
New York
|
-$72.1M |
| 5 |
JCM
Junto Capital Management
New York
|
-$52.2M |
EHC Hedge Fund Activity: Q4 2024 in Review
544 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Encompass Health (EHC) for Q4 2024, worth a combined $8.84B — down 4.3% from $9.24B a quarter earlier.
Buyers outnumbered sellers: 98 funds opened new EHC positions and 31 closed out — a net gain of 67 holders — while 208 added to existing stakes and 163 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $163M. The largest seller was William Blair Investment Management, cutting an estimated $142M.
- 544 institutional investors held Encompass Health (EHC) as of Q4 2024, up from 483 in Q3 2024.
- Funds reported $8.84B of Encompass Health stock for Q4 2024, down 4.3% quarter-over-quarter.
- 98 funds opened new Encompass Health positions in Q4 2024 and 31 closed out, a net change of +67 holders.
- The largest Encompass Health buyer in Q4 2024 was T. Rowe Price Investment Management, an estimated $163M added.
- The largest Encompass Health seller in Q4 2024 was William Blair Investment Management, an estimated $142M sold.
Based on aggregated 13F filings for Q4 2024.